Insulin-like growth factor-1 (IGF-1) mediates some of growth hormone (GH) anabolic functions through its receptor, IGF1R. Following ligand binding, intracellular signaling pathways are activated favouring proliferation, cell survival, tissue growth, development and differentiation. IGF-1 is included in the World Anti-Doping Agency Prohibited List. While the evidences for IGF-1 as performance enhancing substrate in healthy humans are still weak, clinical studies demonstrated that the endogenous GH/IGF-1 excess is associated with cardiovascular implications. Previously, we demonstrated that human peripheral lymphocytes (PBL) represent a suitable system to identify a gene signature, related to dihydrotestosterone (DHT) or IGF-1 abuse, independent from the type of sport. In addition, in a proteomic study, we demonstrated that DHT hyperdosage affects cell motility and apoptosis. Here we investigate the doping action of IGF-1 by means of a differential proteomic approach and specific protein arrays, revealing an active cytoskeletal reorganization mediated by Stat-1; moreover, IGF-1 stimulation produces a sustained activation of different signaling pathways as well as an overproduction of cytokines positively related to immune response and inflammation. In conclusion, these data indicate that, following IGF-1 hyperdosage, circulating PBL could be more prone to transendothelial migration.

Insulin-like growth factor 1 receptor signaling induced by supraphysiological doses of IGF-1 in human peripheral blood lymphocytes

SPAZIANI, SARA;IMPERLINI, Esther;MANCINI, Annamaria;BUONO, Pasqualina;ORRU', STEFANIA
2014

Abstract

Insulin-like growth factor-1 (IGF-1) mediates some of growth hormone (GH) anabolic functions through its receptor, IGF1R. Following ligand binding, intracellular signaling pathways are activated favouring proliferation, cell survival, tissue growth, development and differentiation. IGF-1 is included in the World Anti-Doping Agency Prohibited List. While the evidences for IGF-1 as performance enhancing substrate in healthy humans are still weak, clinical studies demonstrated that the endogenous GH/IGF-1 excess is associated with cardiovascular implications. Previously, we demonstrated that human peripheral lymphocytes (PBL) represent a suitable system to identify a gene signature, related to dihydrotestosterone (DHT) or IGF-1 abuse, independent from the type of sport. In addition, in a proteomic study, we demonstrated that DHT hyperdosage affects cell motility and apoptosis. Here we investigate the doping action of IGF-1 by means of a differential proteomic approach and specific protein arrays, revealing an active cytoskeletal reorganization mediated by Stat-1; moreover, IGF-1 stimulation produces a sustained activation of different signaling pathways as well as an overproduction of cytokines positively related to immune response and inflammation. In conclusion, these data indicate that, following IGF-1 hyperdosage, circulating PBL could be more prone to transendothelial migration.
File in questo prodotto:
File Dimensione Formato  
042_Proteomics2014_proofs.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: DRM non definito
Dimensione 1.93 MB
Formato Adobe PDF
1.93 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11367/29089
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 24
social impact